News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,263 Results
Type
Article (29)
Press Release (3234)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (1)
Alliances (44)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (3)
Approvals (110)
Artificial intelligence (1)
Autoimmune disease (1)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (11)
Cancer (93)
Cardiovascular disease (8)
Career advice (1)
Cervical cancer (1)
Clinical research (680)
Collaboration (4)
Compensation (3)
COVID-19 (4)
Data (127)
Depression (1)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1514)
Events (351)
FDA (157)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (4)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (28)
Healthcare (85)
IgA nephropathy (1)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (38)
Lymphoma (10)
Manufacturing (1)
MASH (4)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (6)
Multiple sclerosis (6)
NASH (1)
Neuroscience (46)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (2)
Pancreatic cancer (1)
Parkinson's disease (2)
Patient recruitment (1)
Peanut (1)
People (8)
Phase I (100)
Phase II (204)
Phase III (407)
Pipeline (104)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (3)
Radiopharmaceuticals (6)
Rare diseases (8)
Regulatory (153)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
Schizophrenia (4)
Sponsored (1)
Startups (3)
Vaccines (5)
Date
Last 7 days (11)
Last 30 days (32)
Last 365 days (420)
2025 (346)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (353)
Australia (14)
California (84)
Canada (26)
China (18)
Connecticut (5)
Delaware (19)
Europe (651)
Florida (12)
Georgia (2)
Illinois (9)
Indiana (19)
Japan (16)
Maryland (17)
Massachusetts (69)
Minnesota (7)
New Jersey (77)
New York (37)
North Carolina (11)
Northern California (59)
Ohio (3)
Pennsylvania (30)
South America (5)
Southern California (19)
Texas (14)
United States (421)
Utah (7)
Virginia (1)
Washington State (5)
3,263 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Regeneron Reports Third Quarter 2025 Financial and Operating Results
October 28, 2025
·
31 min read
Press Releases
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
October 19, 2025
·
18 min read
Press Releases
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
October 20, 2025
·
13 min read
Press Releases
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance
October 31, 2025
·
23 min read
Sponsored
Rosnilimab Shows Promise as a Potential Next-Generation RA Therapy
A depleter of pathogenic T cells, rosnilimab’s novel MOA generated a differentiated efficacy, tolerability and safety profile in recent Phase 2b study
September 15, 2025
·
7 min read
Press Releases
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
September 1, 2025
·
14 min read
Press Releases
New data for Roche’s Vabysmo reinforce its efficacy, safety and durability in neovascular or “wet” age-related macular degeneration (nAMD)
September 5, 2025
·
13 min read
Press Releases
Takeda’s FRUZAQLA™ (fruquintinib) publicly reimbursed in Quebec for the treatment of metastatic colorectal cancer (mCRC)
August 29, 2025
·
5 min read
Press Releases
AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
October 13, 2025
·
13 min read
Press Releases
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
October 20, 2025
·
12 min read
1 of 327
Next
